Jesús Fortün

14.1k total citations
194 papers, 5.5k citations indexed

About

Jesús Fortün is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Jesús Fortün has authored 194 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Epidemiology, 118 papers in Infectious Diseases and 33 papers in Surgery. Recurrent topics in Jesús Fortün's work include Antifungal resistance and susceptibility (65 papers), Fungal Infections and Studies (40 papers) and Pneumocystis jirovecii pneumonia detection and treatment (36 papers). Jesús Fortün is often cited by papers focused on Antifungal resistance and susceptibility (65 papers), Fungal Infections and Studies (40 papers) and Pneumocystis jirovecii pneumonia detection and treatment (36 papers). Jesús Fortün collaborates with scholars based in Spain, United States and Italy. Jesús Fortün's co-authors include Pilar Martín‐Dávila, Santiago Moreno, Patricia Muñóz, José María Aguado, Joan Gavaldà, E Gómez-Mampaso, Asunción Moreno, Vicente Pintado, Enrique Navas and Carmen Quereda and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Microbiology Reviews.

In The Last Decade

Jesús Fortün

184 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesús Fortün Spain 43 3.6k 3.3k 1.0k 484 436 194 5.5k
Rafael San Juan Spain 39 2.7k 0.8× 2.1k 0.6× 1.2k 1.1× 306 0.6× 497 1.1× 191 5.2k
Carlos Cervera Spain 42 3.0k 0.8× 1.6k 0.5× 852 0.8× 462 1.0× 750 1.7× 163 4.5k
José María Aguado Spain 48 4.4k 1.2× 3.5k 1.1× 1.9k 1.8× 527 1.1× 764 1.8× 298 7.9k
Francisco López‐Medrano Spain 35 2.4k 0.7× 1.5k 0.5× 823 0.8× 282 0.6× 532 1.2× 213 4.3k
Asunción Moreno Spain 51 5.6k 1.5× 3.9k 1.2× 1.3k 1.3× 962 2.0× 951 2.2× 257 8.2k
Shimon Kusne United States 52 5.7k 1.6× 4.3k 1.3× 1.4k 1.4× 266 0.5× 687 1.6× 160 8.0k
José M. Miró Spain 41 3.9k 1.1× 3.3k 1.0× 1.2k 1.1× 1.2k 2.4× 157 0.4× 223 6.2k
George Alangaden United States 34 2.2k 0.6× 2.5k 0.8× 431 0.4× 233 0.5× 260 0.6× 129 4.3k
Mario Fernández‐Ruiz Spain 35 2.1k 0.6× 1.9k 0.6× 856 0.8× 373 0.8× 448 1.0× 228 4.8k
Albert Pahissa Spain 45 4.2k 1.2× 3.1k 0.9× 780 0.8× 1.2k 2.5× 151 0.3× 140 6.3k

Countries citing papers authored by Jesús Fortün

Since Specialization
Citations

This map shows the geographic impact of Jesús Fortün's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Fortün with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Fortün more than expected).

Fields of papers citing papers by Jesús Fortün

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Fortün. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Fortün. The network helps show where Jesús Fortün may publish in the future.

Co-authorship network of co-authors of Jesús Fortün

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Fortün. A scholar is included among the top collaborators of Jesús Fortün based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Fortün. Jesús Fortün is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anaya, Brayan J., et al.. (2025). Stability of Ceftobiprole Medocaril in Portable Elastomeric Infusion Devices. Infectious Diseases and Therapy. 14(8). 1685–1696.
2.
Lario, Ana Rodríguez‐Villa, et al.. (2025). When Fungal Prophylaxis Fails: A Rare Case of Rhodotorula mucilaginosa Fungemia with Suspected Abdominal Origin. Journal of Fungi. 11(10). 723–723. 1 indexed citations
3.
Machado, Marina, Jesús Fortün, & Patricia Muñóz. (2024). Invasive aspergillosis: A comprehensive review. Medicina Clínica (English Edition). 163(4). 189–198.
4.
Fernández‐Ruiz, Mario, Juan José Castón, José Luís del Pozo, et al.. (2024). ¿Cómo podemos optimizar el abordaje diagnóstico y terapéutico de la neumonía? Recomendaciones basadas en una opinión de expertos. Enfermedades Infecciosas y Microbiología Clínica. 42(8). 442–452.
5.
Fortün, Jesús, Cruz Soriano, David Pestaña, et al.. (2023). Invasive Pulmonary Aspergillosis in Patients with and without SARS-CoV-2 Infection. Journal of Fungi. 9(2). 130–130. 6 indexed citations
6.
Thompson, George R., Àlex Soriano, Patrick M. Honoré, et al.. (2023). Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials. The Lancet Infectious Diseases. 24(3). 319–328. 43 indexed citations
7.
Martín‐Dávila, Pilar, Francesca Norman, Jesús Fortün, et al.. (2018). Donor‐derived multiorgan transmission of mixed P. malariae and P. ovale infection: Impact of globalization on post‐transplant infections. Transplant Infectious Disease. 20(5). e12938–e12938. 10 indexed citations
8.
9.
10.
García, Andrés González, et al.. (2018). Changes in tuberculosis in human immunodeficiency virus infected patients in a Spanish tertiary hospital (1995-2013).. PubMed. 31(4). 329–335. 2 indexed citations
11.
Fortün, Jesús & Francesca Gioia. (2017). Candidasis invasiva en el paciente neutropénico. Revista española de quimioterapia. Suplemento. 30(1). 22–25. 3 indexed citations
12.
Vena, Antonio, Patricia Muñóz, Belén Padilla, et al.. (2017). Is routine ophthalmoscopy really necessary in candidemic patients?. PLoS ONE. 12(10). e0183485–e0183485. 31 indexed citations
13.
Juan, Rafael San, Esther Viedma, Fernando Cháves, et al.. (2016). High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-SensitiveStaphylococcus aureus. Emerging infectious diseases. 22(6). 1057–1066. 20 indexed citations
14.
Vallejo, Carlos, Lourdes Vázquez, Enric Carreras, et al.. (2013). Tratamiento de las infecciones fúngicas invasoras en pacientes hematológicos de alto riesgo: ¿Qué hemos aprendido en los pasados 10 años?. Revista española de quimioterapia. Suplemento. 26(4). 378–386. 2 indexed citations
15.
Bárcena, Rafael, Santos del Campo, Arturo Muriel, et al.. (2009). 484 IMPACT OF HIV-COINFECTION ON THE OUTCOME OF VIRAL CIRRHOSIS LIVER TRANSPLANT CANDIDATES AT A REFERENCE CENTER FROM 2001–2008 AND PREDICTORS OF POST-TRANSPLANT SURVIVAL. Journal of Hepatology. 50. S182–S182. 1 indexed citations
16.
Gavaldà, Joan, Óscar Len, Rafael San Juan, et al.. (2005). Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study. Clinical Infectious Diseases. 41(1). 52–59. 217 indexed citations
17.
Moreno, Ana, Ana Moreno, Rafael Bárcena, et al.. (2005). HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-α-2b/ribavirin. Journal of Hepatology. 43(5). 783–790. 22 indexed citations
18.
Fortün, Jesús. (2004). Principales infecciones en el paciente oncológico: manejo práctico. Anales del Sistema Sanitario de Navarra. 27.
19.
Fortün, Jesús, et al.. (2000). Extra-laryngeal head and neck tuberculosis. Clinical Microbiology and Infection. 6(12). 644–648. 32 indexed citations
20.
Figueroa, Marta S., et al.. (1997). Famciclovir for the Treatment of Acute Retinal Necrosis (ARN) Syndrome. American Journal of Ophthalmology. 123(2). 255–257. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rafael San Juan Breakdown of academic impact, for papers by Carlos Cervera Breakdown of academic impact, for papers by José María Aguado Breakdown of academic impact, for papers by Francisco López‐Medrano Breakdown of academic impact, for papers by Asunción Moreno Breakdown of academic impact, for papers by Shimon Kusne Breakdown of academic impact, for papers by José M. Miró Breakdown of academic impact, for papers by George Alangaden Breakdown of academic impact, for papers by Mario Fernández‐Ruiz Breakdown of academic impact, for papers by Albert Pahissa
Rankless by CCL
2026